日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma.

白细胞分离术产品中的单核细胞会影响 CD19 靶向 CAR T 细胞疗法治疗淋巴瘤患者的疗效

Carniti Cristiana, Caldarelli Nicole M, Agnelli Luca, Torelli Tommaso, Ljevar Silva, Jonnalagadda Sadhana, Zanirato Giada, Fardella Eugenio, Stella Federico, Lorenzini Daniele, Brich Silvia, Arienti Flavio, Dodero Anna, Chiappella Annalisa, Magni Martina, Corradini Paolo

PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

PEOPLE (NTC03447678) 是一项 II 期临床试验,旨在评估帕博利珠单抗作为一线治疗方案在 PD-L1 <50% 的晚期非小细胞肺癌患者中的疗效:一项多组学分析

Lo Russo, Giuseppe; Prelaj, Arsela; Dolezal, James; Beninato, Teresa; Agnelli, Luca; Triulzi, Tiziana; Fabbri, Alessandra; Lorenzini, Daniele; Ferrara, Roberto; Brambilla, Marta; Occhipinti, Mario; Mazzeo, Laura; Provenzano, Leonardo; Spagnoletti, Andrea; Viscardi, Giuseppe; Sgambelluri, Francesco; Brich, Silvia; Miskovic, Vanja; Pedrocchi, Alessandra Laura Giulia; Trovo', Francesco; Manglaviti, Sara; Giani, Claudia; Ambrosini, Paolo; Leporati, Rita; Franza, Andrea; McCulloch, John; Torelli, Tommaso; Anichini, Andrea; Mortarini, Roberta; Trinchieri, Giorgio; Pruneri, Giancarlo; Torri, Valter; De Braud, Filippo; Proto, Claudia; Ganzinelli, Monica; Garassino, Marina Chiara